ATRA
Atara Biotherapeutics Inc
Price:  
13.03 
USD
Volume:  
31,906.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atara Relative Valuation

-4996.8%
Upside

As of 2024-12-09, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is (638.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.03 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is -4996.8%.

The range of the Relative Valuation is (650.08) - (728.68) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.1x - 45.1x 34.6x
Forward P/E multiples 19.8x - 31.5x 20.6x
Fair Price (650.08) - (728.68) (638.06)
Upside -5089.1% - -5692.3% -4996.8%
13.03 USD
Stock Price
(638.06) USD
Fair Price

Atara Relative Valuation - Historical P/E Data

Date P/E
2024-11-25 -0.52
2024-11-22 -0.50
2024-11-21 -0.46
2024-11-20 -0.46
2024-11-19 -0.48
2024-11-18 -0.49
2024-11-15 -0.52
2024-11-14 -0.55
2024-11-13 -0.62
2024-11-12 -0.50
2024-11-11 -0.51
2024-11-08 -0.49
2024-11-07 -0.44
2024-11-06 -0.43
2024-11-05 -0.44
2024-11-04 -0.50
2024-11-01 -0.42
2024-10-31 -0.39
2024-10-30 -0.41
2024-10-29 -0.38
2024-10-28 -0.38
2024-10-25 -0.37
2024-10-24 -0.37
2024-10-23 -0.37
2024-10-22 -0.39
2024-10-21 -0.40
2024-10-18 -0.41
2024-10-17 -0.41
2024-10-16 -0.40
2024-10-15 -0.36
2024-10-14 -0.35
2024-10-11 -0.35
2024-10-10 -0.34
2024-10-09 -0.34
2024-10-08 -0.34
2024-10-07 -0.33
2024-10-04 -0.33
2024-10-03 -0.31
2024-10-02 -0.33
2024-10-01 -0.33
2024-09-30 -0.35
2024-09-27 -0.35
2024-09-26 -0.33
2024-09-25 -0.32
2024-09-24 -0.33
2024-09-23 -0.32
2024-09-20 -0.34
2024-09-19 -0.34
2024-09-18 -0.34
2024-09-17 -0.37